Mycolicibacterium mageritense Bacteremia Following Partial Nephrectomy: A Case Report. [PDF]
Castro R.
europepmc +1 more source
This study reveals the dual role of celecoxib in intervertebral disc degeneration. While low concentrations are protective, high concentrations induce toxicity by upregulating HSP90, which synergizes with USP15 to deubiquitinate and stabilize RBX1. This leads to degradation of COMMD1/ATP7B, copper dyshomeostasis, and ultimately, cuproptosis.
Youfeng Guo +11 more
wiley +1 more source
Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting. [PDF]
Mushtaq W +5 more
europepmc +1 more source
A pathogen‐centric antibody‐antibiotic conjugate (AZO‐AAC) releases antibiotics via bacterial azoreductase, independent of host‐lysosomal function. This mechanism achieves nanomolar eradication of both planktonic and intracellular methicillin‐resistant Staphylococcus aureus (MRSA).
Qi Cheng +13 more
wiley +1 more source
Pazopanib combined with doxorubicin and cisplatin in recurrent osteosarcoma: A retrospective cohort study. [PDF]
Cai WL +6 more
europepmc +1 more source
Decoding Undesirable Inflammatory Responses of Nucleic Acid‐Delivering Lipid Nanoparticles
Lipid nanoparticles (LNPs) enable efficient nucleic acid delivery, but their immunogenicity is a double‐edged sword. This review explores LNP‐driven innate and adaptive immunity, covering lipid components, endosomal escape, and nucleic acid sensing.
Ruimin Hu +6 more
wiley +1 more source
Medication adherence rates in patients with ocular inflammatory disease. [PDF]
Chew ZRJ +5 more
europepmc +1 more source
Optimizing safety and efficacy in radiotherapy for external auditory canal cancer. [PDF]
Imai Y +17 more
europepmc +1 more source
In Regard to Prabhu et al. [PDF]
Marwaha AS, Shepard MJ, Wegner RE.
europepmc +1 more source
Endoscopic resection as a "resect-to-confirm" strategy after neoadjuvant downstaging for remnant gastric cancer. [PDF]
Zuo X +6 more
europepmc +1 more source

